Coya Therapeutics (COYA) closed at $2.98 on November 19, 2026, down 3.6% from the previous close, on volume of 71,111 shares (30-day average 168,982).
Data as of November 19, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 21, 2026 | Calendar Put Spread | 19-Feb : 21-May-27 2.5 P | 442 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 18, 2026. See the largest for 5, 30, 60 and 90 days
Coya Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update
Business Wire (Tue, 10-Nov 8:00 AM ET)
Business Wire (Wed, 28-Oct 8:00 AM ET)
Coya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS
Business Wire (Wed, 14-Oct 8:00 AM ET)
COYA Joins Chardan Healthcare Conference Panel on ALS, Alzheimer’s, and Parkinson’s
Market Chameleon (Tue, 13-Oct 7:40 AM ET)
Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
Business Wire (Tue, 13-Oct 8:00 AM ET)
Business Wire (Mon, 5-Oct 8:00 AM ET)
Business Wire (Tue, 15-Sep 8:00 AM ET)
Business Wire (Tue, 8-Sep 8:00 AM ET)
Market Chameleon (Tue, 4-Nov 3:42 AM ET)
COYA’s $20 Million Upsized Public Offering: Funding Next Steps in Neurodegenerative Research
Market Chameleon (Fri, 24-Oct 3:31 AM ET)
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Coya Therapeutics trades on the NASDAQ stock market under the symbol COYA.
As of November 19, 2026, COYA stock price declined to $2.98 with 71,111 million shares trading.
COYA has a beta of 2.00, meaning it tends to be more sensitive to market movements. COYA has a correlation of 0.17 to the broad based SPY ETF.
COYA has a market cap of $69.90 million. This is considered a Micro Cap stock.
Last quarter Coya Therapeutics reported $234,134 in Revenue and -$.45 earnings per share. This beat revenue expectation by $155,564 and missed earnings estimates by -$.10.
In the last 3 years, COYA traded as high as $10.69 and as low as $2.72.
The top ETF exchange traded funds that COYA belongs to (by Net Assets): VTI, VXF, DFAS, IWC, DFMC.
COYA has underperformed the market in the last year with a return of -51.6%, while the SPY ETF gained +9.6%. In the last 3 month period, COYA fell short of the market, returning -39.4%, while SPY returned -6.5%. However, in the most recent 2 weeks COYA has outperformed the stock market by returning -3.2%, while SPY returned -6.6%.
COYA support price is $2.90 and resistance is $3.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COYA shares will trade within this expected range on the day.